Connection
Everett E. Vokes to Hematinics
This is a "connection" page, showing publications Everett E. Vokes has written about Hematinics.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.024 |
|
|
|
-
Miller AA, Wang XF, Gu L, Hoffman P, Khatri J, Dunphy F, Edelman MJ, Bolger M, Vokes EE, Green MR. Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). J Thorac Oncol. 2008 Oct; 3(10):1159-65.
Score: 0.024